Monitoring of Hypnosis State During General Anesthesia With Propofol by Patient State Index From SEDLine®

Sponsor
Hospital Universitario de Canarias (Other)
Overall Status
Completed
CT.gov ID
NCT02706665
Collaborator
Masimo Corporation (Industry)
12
1
29
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is the evaluation of possible relationships and correlation between PSI values obtained from the SEDLine® monitor and the infusion rate of propofol during general anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Other: SEDline monitor

Detailed Description

Introduction:

There is a large intra-and interindividual variability in the effect of propofol. To deal with this problem, a real-time monitoring and therefore a more accurate titration of anesthetic agents is proposed. Brain function monitors based on a processed analysis of EEG (Electroencephalogram) can help to control pharmacodynamic effects of hypnotic agents. PSI values provide a measurement of the hypnotic effect of propofol. It will be observed an inverse correlation between the propofol infusion rate and the PSI value.

Objectives:

To design a computer program to record simultaneously the propofol infusion rate, PSI and Electromyogram (EMG).

To study the correlation between PSI values obtained from the SEDLine® monitor and the infusion rate of propofol during general anesthesia.

To obtain a mathematical model of the system from data recorded with different identification techniques.

Methods:

A group of patients scheduled for surgery under a standard total intravenous anesthesia (TIVA) with propofol and remifentanil will be recruited. The hypnotic effect of propofol will be monitored with the PSI from a SEDline monitor continuously. All anesthetic doses and their changes fall within conventional dosing.

The procedure for recording data and obtaining the pharmacokinetics/pharmacodynamics (PK / PD) model will be connecting a SEDLine® monitor to a laptop with an original program developed by members of our team. The program automatically stores the infusion rate of propofol (mg/kg/h) and the simultaneous values of PSI and frontal EMG. Graphics and data collected will be explored with various systems of techniques for pattern recognition in order to get the best fit to define a mathematical model of the dose of propofol and PSI values. A subsequent computer analysis with MATLAB® will estimate the correlation between the infusion of propofol infusion rate and PSI values.

Study Design

Study Type:
Observational
Actual Enrollment :
12 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Modelling Pharmacokinetic/Pharmacodynamic of Propofol Based on PSI Values From the SEDline®
Study Start Date :
Dec 1, 2015
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
May 1, 2018

Outcome Measures

Primary Outcome Measures

  1. EEG processed will be measured by non invasive adhesive electrodes on the skin of the forehead's patient. A disposable sensor connected with a SEDLine provides de PSI index [During general anaesthesia in the operating room for a scheduled surgery.]

    The values from the SEDLine ® monitor inversely correlate with the rate of infusion of propofol. Changes in that velocity correspond to changes in the effect site (CNS) and are related to the PSI values displayed in the monitor.

Secondary Outcome Measures

  1. Time from discontinuation of intravenous agents to open eyes to order [In the operation room at the end of surgery]

    It will be measured with a chronometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American Society of Anesthesiologists classification of I, II, or III

  • Patient signed an informed consent

Exclusion Criteria:
  • Patients with prior neurological disease, epilepsy or stroke.

  • Patients who are receiving drug therapy that may alter processed EEG monitoring and decrease the PSI accuracy.

  • American Society of Anesthesiologists classification IV or higher

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Universitario de Canarias La Laguna Santa Cruz De Tenerife Spain 38320

Sponsors and Collaborators

  • Hospital Universitario de Canarias
  • Masimo Corporation

Investigators

  • Principal Investigator: Jose Antonio Reboso Morales, MD, PhD, Hospital Universitario de Canarias

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Universitario de Canarias
ClinicalTrials.gov Identifier:
NCT02706665
Other Study ID Numbers:
  • 2013_10
First Posted:
Mar 11, 2016
Last Update Posted:
Oct 17, 2019
Last Verified:
Mar 1, 2016
Keywords provided by Hospital Universitario de Canarias

Study Results

No Results Posted as of Oct 17, 2019